BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17725546)

  • 1. Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains.
    Villar D; Vara-Vega A; Landázuri MO; Del Peso L
    Biochem J; 2007 Dec; 408(2):231-40. PubMed ID: 17725546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HIF-prolyl hydroxylases binding to substrates.
    Landázuri MO; Vara-Vega A; Vitón M; Cuevas Y; del Peso L
    Biochem Biophys Res Commun; 2006 Dec; 351(2):313-20. PubMed ID: 17069766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme substrate recognition in oxygen sensing: how the HIF trap snaps.
    Metzen E
    Biochem J; 2007 Dec; 408(2):e5-6. PubMed ID: 17990984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
    Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
    Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
    Tuckerman JR; Zhao Y; Hewitson KS; Tian YM; Pugh CW; Ratcliffe PJ; Mole DR
    FEBS Lett; 2004 Oct; 576(1-2):145-50. PubMed ID: 15474027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.
    Pappalardi MB; Martin JD; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Lor L; Schwartz B; Duffy K; Gontarek R; Tummino PJ; Copeland RA; Luo L
    Biochemistry; 2008 Oct; 47(43):11165-7. PubMed ID: 18834144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene.
    Pescador N; Cuevas Y; Naranjo S; Alcaide M; Villar D; Landázuri MO; Del Peso L
    Biochem J; 2005 Aug; 390(Pt 1):189-97. PubMed ID: 15823097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen.
    del Peso L; Castellanos MC; Temes E; Martin-Puig S; Cuevas Y; Olmos G; Landazuri MO
    J Biol Chem; 2003 Dec; 278(49):48690-5. PubMed ID: 14506252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
    Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
    Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity.
    Wirthner R; Balamurugan K; Stiehl DP; Barth S; Spielmann P; Oehme F; Flamme I; Katschinski DM; Wenger RH; Camenisch G
    Methods Enzymol; 2007; 435():43-60. PubMed ID: 17998048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
    To KK; Huang LE
    J Biol Chem; 2005 Nov; 280(45):38102-7. PubMed ID: 16157596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors.
    Tug S; Delos Reyes B; Fandrey J; Berchner-Pfannschmidt U
    Biochem Biophys Res Commun; 2009 Jul; 384(4):519-23. PubMed ID: 19427832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
    Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
    Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.
    Strocchi S; Reggiani F; Gobbi G; Ciarrocchi A; Sancisi V
    Oncogene; 2022 Jul; 41(29):3665-3679. PubMed ID: 35705735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
    Alcaide-German ML; Vara-Vega A; Garcia-Fernandez LF; Landazuri MO; del Peso L
    BMC Cell Biol; 2008 Apr; 9():18. PubMed ID: 18402654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oxygen molecular sensor, the HIF prolyl 4-hydroxylase, in the marine protist Perkinsus olseni.
    Leite RB; Brito AB; Cancela ML
    Protist; 2008 Jul; 159(3):355-68. PubMed ID: 18539525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity.
    Cervera AM; Apostolova N; Luna-Crespo F; Sanjuan-Pla A; Garcia-Bou R; McCreath KJ
    Cancer Lett; 2006 Feb; 233(1):131-8. PubMed ID: 16473674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.
    Lieb ME; Menzies K; Moschella MC; Ni R; Taubman MB
    Biochem Cell Biol; 2002; 80(4):421-6. PubMed ID: 12234095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.